Biosynthesis method for producing 3, 5-dihydroxy-4-methoxybenzyl alcohol by using bacillus subtilis
By constructing recombinant plasmids to synthesize DHMBA in Bacillus subtilis, the limitations of high-temperature treatment in existing technologies have been overcome, achieving efficient and economical DHMBA biosynthesis suitable for industrial production.
Patent Information
- Application Number
- CN202411257592.5
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-09-09
- Publication Date
- 2024-11-22
AI Technical Summary
Existing technologies make it difficult to efficiently synthesize 3,5-dihydroxy-4-methoxybenzyl alcohol (DHMBA) through genetic engineering, and traditional extraction methods have limitations due to high-temperature processing.
DHMBA was obtained by constructing a recombinant plasmid containing carboxylic acid reductase and O-methyltransferase genes, transforming it into Bacillus subtilis, and biosynthesizing it in a culture medium containing shikimic acid. Finally, it was isolated and purified.
A highly efficient, economical, and environmentally friendly DHMBA biosynthesis method has been developed, which is suitable for industrial production.
Smart Images

Figure CN118995834A_ABST
Abstract
Description
Technical Field
[0001] The invention belongs to the field of genetic engineering and biotechnology, and specifically relates to a biosynthetic method for producing 3,5-dihydroxy-4-methoxybenzyl alcohol by utilizing Bacillus subtilis. Background Art
[0002] 3,5-dihydroxy-4-methoxybenzyl alcohol (DHMBA) contains three hydroxyl groups and has a chemical formula of C8H 10 O4 is a phenolic organic compound extracted from filter-feeding bivalve molluscs, which has a powerful antioxidant effect. DHMBA is a rare indirect antioxidant that has both rapid-acting direct antioxidant and sustainable antioxidant capacity. Due to its hydrophilic and lipophilic properties, it can penetrate into oily cell membranes and water-rich cells, and the active oxygen free radicals deep in the cells will also be fully oxidized and eliminated. Studies have shown that the antioxidant activity of DHMBA is about 2.3 times that of the representative antioxidant vitamin C, and 6 times that of chlorogenic acid. At the same time, the safety of DHMBA (IC 50 ) is 5 times that of curcumin and lycopene, and is a safe and stable super antioxidant.
[0003] In terms of physiological functions, DHMBA is particularly beneficial to liver health, and can protect liver cells from damage and apoptosis caused by oxidative stress. At the same time, DHMBA helps the normal functioning of glutamatergic neuron activity, helps the brain's memory and learning functions, and reduces emotional anxiety. Secondly, it helps reduce weight and fatty liver. It also has the functions of accelerating the penetration of the blood-brain barrier, promoting sleep, improving memory, delaying Alzheimer's disease, promoting fur regeneration, and preventing hair loss. The relevant effects are supported by a large amount of clinical data as well as animal models and cell experimental tests.
[0004] In summary, DHMBA is a powerful and safe antioxidant with great development prospects in the beauty and daily chemical, pet feed, health care products, pharmaceutical and other industries.
[0005] The Chinese patent "Method for Generating 3,5-dihydroxy-4-methoxybenzyl alcohol from oyster meat" with patent application number CN201480081399.9 mentioned for the first time that 3,5-dihydroxy-4-methoxybenzyl alcohol was obtained by processing oyster meat. This method is to heat the oyster meat directly at a temperature above 98°C, or heat it at a temperature above 90°C after pressurization, which belongs to the extraction method of DHMBA. The Chinese patent "Method for Fermentation Preparation of 3,5-Dihydroxy-4-Methoxybenzyl Alcohol and Application of the Method" with patent application number CN202310206016.7 mentioned the use of oyster meat for fermentation to obtain oyster meat powder containing DHMBA. Since DHMBA was originally found in oysters, this method imitates the natural production method of DHMBA, and does not synthesize DHMBA through genetic engineering. Summary of the invention
[0006] In view of the problems existing in the prior art, the object of the present invention is to provide a biosynthetic method for producing DHMBA using Bacillus subtilis. The method uses genetic engineering to construct a recombinant plasmid containing key enzyme genes required for synthesizing DHMBA, and transforms it into Bacillus subtilis, so that it can be biosynthesized in a culture medium containing shikimic acid, and finally obtains DHMBA by separation and purification.
[0007] In order to achieve the above-mentioned object of the invention, the present invention provides the following technical solutions:
[0008] A biosynthetic method for producing DHMBA using Bacillus subtilis comprises the following steps:
[0009] (1) constructing a recombinant plasmid containing carboxylic acid reductase and O-methyltransferase genes;
[0010] (2) transforming the recombinant plasmid into Bacillus subtilis to obtain recombinant Bacillus subtilis;
[0011] (3) culturing the recombinant Bacillus subtilis in a culture medium containing shikimic acid;
[0012] (4) Isolate and purify DHMBA from the culture medium.
[0013] The carboxylic acid reductase is derived from Streptomyces, and its encoding gene is the carA gene, and the nucleotide sequence is shown in SEQ ID NO.1.
[0014] The O-methyltransferase is derived from Streptomyces, and its encoding gene is the omt gene, and the nucleotide sequence is shown in SEQ ID NO.2.
[0015] In the above biosynthesis method, the specific metabolic pathway is as follows:
[0016] In the first step, shikimic acid is converted into 3,4,5-trihydroxy-1-cyclohexene-1-carbaldehyde (DHBA) by carboxylic acid reductase;
[0017] In the second step, 3,4,5-trihydroxy-1-cyclohexene-1-carbaldehyde (DHBA) is methylated to DHMBA by O-methyltransferase.
[0018] In step (3), the culture conditions are: pH value is 6.5-7.5, temperature is 32-40°C, and time is 24-72h.
[0019] Preferably, the culture conditions are: pH value is 6.5-7.5, temperature is 34-36°C, and time is 48-60h.
[0020] In step (3), the culture medium consists of 20-30 g / L glucose, 5 g / L yeast extract, 10 g / L sodium chloride, and the solvent is water.
[0021] In step (3), the concentration of shikimic acid in the culture medium is 1-10 g / L.
[0022] Preferably, the concentration of shikimic acid in the culture medium is 6-8 g / L.
[0023] In step (4), the separation and purification is carried out using high performance liquid chromatography.
[0024] The present invention also provides application of the above-mentioned biosynthetic method for producing DHMBA by using Bacillus subtilis in preparing DHMBA.
[0025] The present invention proposes a biosynthesis method of DHMBA for the first time, which uses genetic engineering to construct a recombinant plasmid containing a key enzyme gene required for synthesizing DHMBA, and transforms it into Bacillus subtilis, so that it can be biosynthesized in a culture medium containing shikimic acid, and finally obtains DHMBA by separation and purification. The method is efficient, economical, and environmentally friendly, and is suitable for industrial production. BRIEF DESCRIPTION OF THE DRAWINGS
[0026] Figure 1 The effect of different temperatures on the expression level of DHMBA.
[0027] Figure 2 This is the effect of different glucose concentrations on the expression of DHMBA.
[0028] Figure 3 The effect of different shikimic acid concentrations on the expression of DHMBA.
[0029] Figure 4 The effect of different fermentation times on the expression level of DHMBA. DETAILED DESCRIPTION
[0030] The following examples are provided to further illustrate the present invention, rather than to limit the present invention.
[0031] Example 1
[0032] The preparation method of the recombinant plasmid and strain for synthesizing the genes required for DHMBA is as follows:
[0033] (1) Gene acquisition:
[0034] A. Carboxylic acid reductase (carA gene) and O-methyltransferase (omt gene) gene sequences were amplified from Streptomyces by PCR technology, and specific primers were used for PCR amplification to obtain DNA fragments of the target genes.
[0035] The carA gene sequence is shown in SEQ ID NO.1:
[0036]
[0037] The omt gene sequence is shown in SEQ ID NO.2:
[0038]
[0039] B. Check the quality of the PCR amplification product and confirm the presence of the target gene using agarose gel electrophoresis.
[0040] (2) Selection and preparation of carriers
[0041] A. Select the plasmid vector pHT01 suitable for Bacillus subtilis expression.
[0042] B. Use restriction endonucleases (EcoRI and BamHI) to digest the vector to generate sticky ends or blunt ends compatible with the ends of the target gene.
[0043] C. Dephosphorylate the vector after enzyme digestion to prevent self-cyclization.
[0044] (3) Cloning and ligation of target genes
[0045] A. The PCR-amplified carA and omt genes were digested with the same restriction endonucleases as the vector to generate ends that are compatible with the vector.
[0046] B. Mix the target gene and vector after enzyme digestion in an appropriate proportion, add T4 DNA ligase, and carry out ligation reaction to form a recombinant plasmid.
[0047] (4) Transformation and screening of recombinant plasmids
[0048] A. Use electroporation to introduce the recombinant plasmid into Bacillus subtilis competent cells.
[0049] B. Spread the transformed Bacillus subtilis on a selective culture medium plate containing an appropriate antibiotic (chloramphenicol), culture for 24-48 hours, and screen out antibiotic-resistant strains containing the recombinant plasmid.
[0050] C. Take several antibiotic-resistant strains and verify whether the recombinant plasmid contains the target gene through plasmid extraction and PCR. The correctness of the recombinant plasmid is further confirmed by sequencing.
[0051] (5) Functional verification of recombinant plasmids
[0052] A. Inoculate Bacillus subtilis containing the recombinant plasmid into appropriate culture medium to induce gene expression.
[0053] B. Use SDS-PAGE and Western Blot techniques to detect the expression of carboxylic acid reductase and O-methyltransferase.
[0054] C. Extract crude enzyme solution from engineered bacteria, perform in vitro enzyme activity assay, and confirm the functions of carboxylic acid reductase and O-methyltransferase.
[0055] The culture medium and culture method required for synthesizing DHMBA are as follows:
[0056] Prepare the basal medium as follows, adjust the pH to 6.5-7.5:
[0057]
[0058] Prepare different concentrations of shikimic acid solutions, dissolve shikimic acid in sterile water, filter and sterilize through a 0.22 μm filter membrane after dissolution, and store the shikimic acid solution in a 4°C refrigerator for later use.
[0059] Sterilize the basal medium and cool it to below 50°C, add shikimic acid solution to a final concentration of 1-10 g / L. Add kanamycin solution to a final concentration of 50 μg / mL. Mix well and dispense into sterile culture bottles.
[0060] Take an appropriate amount of overnight culture solution and inoculate it into the culture medium containing shikimic acid at a volume ratio of 1:100 (for example, inoculate 1 mL of overnight culture solution into 100 mL of culture medium). Cultivate in a shaker (200 rpm) at different temperatures. Cultivation temperature: 32-40°C. Cultivation time: 24-72 hours.
[0061] Take an appropriate amount of culture medium and centrifuge (6000×g, 10 minutes), collect the supernatant, detect DHMBA in the supernatant using high performance liquid chromatography (HPLC), and calculate the concentration of DHMBA based on the standard curve drawn with the standard product.
[0062] The DHMBA in the fermentation broth was extracted with ethyl acetate. The organic phase was collected and the solvent was evaporated to obtain a crude product. The crude product was purified using column chromatography.
[0063] Example 2
[0064] Effects of different fermentation temperatures on DHMBA expression:
[0065] Use the following conditions for fermentation culture and discuss the effect of fermentation temperature:
[0066] Glucose concentration: 20 g / L;
[0067] Shikimic acid concentration: 5g / L;
[0068] Fermentation time: 48 hours;
[0069] Fermentation temperature: 32°C, 34°C, 36°C, 38°C, 40°C;
[0070] After the fermentation is completed, the concentration of DHMBA in the fermentation supernatant is tested. The test results are shown in Figure 1Different temperatures have a great influence on the expression of DHMBA, and the optimal fermentation temperature is between 34-36℃.
[0071] Example 3
[0072] Effects of different glucose concentrations on DHMBA expression:
[0073] Use the following conditions for fermentation and discuss the effect of glucose concentration:
[0074] Fermentation temperature: 36°C;
[0075] Shikimic acid concentration: 5g / L;
[0076] Fermentation time: 48 hours;
[0077] Glucose concentration: 10g / L, 15g / L, 20g / L, 25g / L, 30g / L;
[0078] After the fermentation is completed, the concentration of DHMBA in the fermentation supernatant is tested. The test results are shown in Figure 2 Different glucose concentrations had a great influence on the expression of DHMBA, and the optimal glucose concentration was between 20-30 g / L.
[0079] Example 4
[0080] Effects of different concentrations of shikimic acid on the expression of DHMBA:
[0081] The following conditions were used for fermentation and the effect of shikimic acid concentration was discussed:
[0082] Fermentation temperature: 36°C;
[0083] Glucose concentration: 25 g / L;
[0084] Fermentation time: 48 hours;
[0085] Shikimic acid concentration: 1g / L, 2g / L, 4g / L, 6g / L, 8g / L, 10g / L;
[0086] After the fermentation is completed, the concentration of DHMBA in the fermentation supernatant is tested. The test results are shown in Figure 3 Different shikimic acid concentrations have a great influence on the expression of DHMBA. Low shikimic acid concentrations result in very little synthesis of DHMBA. The optimized shikimic acid concentration is 6-8 g / L.
[0087] Example 5
[0088] Effects of different fermentation times on DHMBA expression:
[0089] The following conditions were used for fermentation culture, and the effect of fermentation time was discussed:
[0090] Fermentation temperature: 36°C;
[0091] Glucose concentration: 25 g / L;
[0092] Fermentation time: 24 hours, 36 hours, 48 hours, 60 hours, 72 hours;
[0093] Shikimic acid concentration: 6g / L;
[0094] After the fermentation is completed, the concentration of DHMBA in the fermentation supernatant is tested. The test results are shown in Figure 4 Different fermentation times had a great influence on the expression of DHMBA. With the increase of fermentation time, DHMBA gradually accumulated, and the growth slowed down after 48 hours of fermentation. The optimal fermentation time was between 48 and 60 hours.
[0095] The above-mentioned embodiments are only some preferred embodiments of the present invention, and cannot be used to limit the scope of protection of the present invention. Any non-substantial changes and substitutions made by technicians in this field on the basis of the present invention shall fall within the scope of protection required by the present invention.
Claims
1. A biosynthetic method for producing 3,5-dihydroxy-4-methoxybenzyl alcohol using Bacillus subtilis, characterized in that: The following steps are involved: (1) constructing a recombinant plasmid containing carboxylic acid reductase and O-methyltransferase genes; (2) transforming the recombinant plasmid into Bacillus subtilis to obtain recombinant Bacillus subtilis; (3) culturing the recombinant Bacillus subtilis in a culture medium containing shikimic acid; (4) 3,5-dihydroxy-4-methoxybenzyl alcohol is isolated and purified from the culture medium.
2. The biosynthesis method according to claim 1, characterized in that The nucleotide sequence of the carboxylic acid reductase is shown in SEQ ID NO.1, and the nucleotide sequence of the O-methyltransferase is shown in SEQ ID NO.
2.
3. The biosynthesis method according to claim 1, characterized in that Its specific metabolic pathway is as follows: In the first step, shikimic acid is converted into 3,4,5-trihydroxy-1-cyclohexene-1-carbaldehyde by carboxylic acid reductase; In the second step, 3,4,5-trihydroxy-1-cyclohexene-1-carbaldehyde is methylated to 3,5-dihydroxy-4-methoxybenzyl alcohol under the action of O-methyltransferase.
4. The biosynthesis method according to claim 1, characterized in that The culture conditions are as follows: pH value is 6.5-7.5, temperature is 32-40° C., and time is 24-72 hours.
5. The biosynthesis method according to claim 4, characterized in that The culture conditions are as follows: pH value is 6.5-7.5, temperature is 34-36° C., and time is 48-60 h.
6. The biosynthesis method according to claim 1, characterized in that: The culture medium consists of 20-30 g / L glucose, 5 g / L yeast extract, 10 g / L sodium chloride, and water as the solvent.
7. The biosynthesis method according to claim 1, characterized in that: The concentration of shikimic acid in the culture medium is 1-10 g / L.
8. The biosynthesis method according to claim 7, characterized in that: The concentration of shikimic acid in the culture medium is 6-8 g / L.
9. The biosynthesis method according to claim 1, characterized in that: The separation and purification is carried out by high performance liquid chromatography.
10. Use of the biosynthetic method for producing 3,5-dihydroxy-4-methoxybenzyl alcohol using Bacillus subtilis according to any one of claims 1 to 9 in the preparation of 3,5-dihydroxy-4-methoxybenzyl alcohol.
Citation Information
Cited By
Biosynthesis method for producing 3,5-dihydroxy-4-methoxybenzyl alcohol using bacillus subtilis
WO2025256666A1
